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General materials and methods  
 
Unless otherwise noted, all chemicals and reagents for chemical reactions were obtained from 
commercial suppliers (Sigma-Aldrich, Acros) and used without further purification. Sonication was 
performed using a Qsonica Q500 sonicator. For UV-vis analyses, spectra were collected between 650 and 
390 nm on a UV1800 Shimadzu spectrophotometer. Circular dichroism (CD) analyses were performed 
using Aviv Biomedical Model 410 CD spectrophotometer. Gas chromatography (GC) analyses were 
carried out using a Shimadzu GC-17A gas chromatograph with FID detector and J&W HP-5 column (30 
m x 0.32 mm, 0.25 µm film) and 2-phenylethanol as an internal standard. Analytical SFC was performed 
with a Mettler SFC supercritical CO2 analytical chromatography system with isopropanol and liquid CO2 
as the mobile phase. Enantiomers were separated using a Chiralpak AS column (4.6 mm x 25 cm) 
obtained from Daicel Chemical Industries, Ltd. High resolution mass spectrometry (HRMS) was 
performed with Agilent 6200 Series TOF with an Agilent G1978A multimode source in electrospray 
ionization (ESI), atmospheric pressure chemical ionization (APCI), or mixed (MM) ionization mode. 
Enzymes (DpnI, Phusion polymerase) were purchased from New England Biolabs (NEB, Ipswich, MA).  
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Generation of enzyme variants  
Plasmid pET22b(+) was used as a cloning and expression vector for all enzymes used in this study. Site-
directed mutagenesis was accomplished by modified QuikChange
TM
 protocol using primers bearing the 
desired mutations (IDT, San Diego, CA). The PCR products were gel purified, digested with DpnI, 
repaired using Gibson Mix
TM
, and used directly to transform E. coli strain BL21(DE3). Variants were 
stored as glycerol stocks at –80 ºC. 
 
Hemochrome binding assay   
A solution of pyridine was made by combining 1.75 mL pyridine with 0.75 mL 1 M NaOH.  The solution 
mixed at room temperature was centrifuged for 30 s at 5000 rcf to remove excess aqueous base.  To a 
cuvette containing 0.75 mL of protein solution in phosphate buffer (0.1 M, pH 8.0), 0.25 mL of the 
pyridine solution was added followed by a few grains (less than 2.0 mg) of sodium dithionite.  The 
cuvette was sealed with parafilm and a UV-vis spectrum was recorded immediately.  P450 concentration 
was determined from the absorbance of the hemochrome complex using extinction coefficient ε418 = 196 
mM
-1
 cm
-1
.  Absorbance was assigned as the difference between the peak max at 418 nm and the baseline 
at 420 nm as determined by extrapolating from two points on either side of the hemochrome peak.   
 
Determination of εmax for ferrous histidine-ligated P450 enzymes 
BM3-HStar holoprotein with known concentration (determined by hemochrome binding assay) was used 
for extinction coefficient determination.  An appropriate amount of the protein was transferred to a semi-
micro cuvette fitted with a screw septum cap (Starna Cells, product number 9-SOG-10-GL14-S). The 
cuvette was made anaerobic by flushing with argon. In 6 mL crimp-sealed vials, a phosphate buffer 
solution (0.1 M, pH = 8.0) and a 12.5 mM solution of sodium dithionite in phosphate buffer (0.1 M, pH = 
8.0) were degassed by bubbling with argon. To the semi-micro cuvette, 700 µL of the degassed 
phosphate buffer and 250 µL of the degassed Na2S2O4 solution were added, and then the UV-vis 
spectrum was recorded. Absorbance was assigned as the difference between the peak max at 424 nm and 
the baseline as determined by extrapolating from two points on either side of the ferrous peak (390 nm 
and 460 nm). The measurement was repeated for five different enzyme concentrations and a calibration 
curve was constructed to determine the ferrous εmax.  
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From the above calibration curve, we determine εmax = 119 mM
-1
cm
-1 
 
Ferrous concentration assay  
Ferrous concentration assay was used to determine the concentration of His-ligated P450-BM3 variant in 
crude lysate.  To an anaerobic cuvette containing 800 µL of P450 lysate of unknown concentration was 
added 200 µL of degassed Na2S2O4 solution (2 mg/mL), and the UV-vis spectrum was recorded.  
Absorbance was assigned as the difference between the peak max at 424 nm and the baseline as 
determined by extrapolating from two points on either side of the ferrous peak (390 nm and 460 nm). 
P450 concentration was determined from the absorbance of the ferrous species using an extinction 
coefficient of ε = 119 mM
-1
 cm
-1
 for histidine-ligated P450-BM3.   
 
P450 expression and purification 
One liter Hyperbrothamp (AthenaES©) was inoculated with an overnight culture (25 mL, LBamp) of 
recombinant E. coli BL21(DE3) cells harboring a pET22b(+) plasmid encoding the P450 variant. The 
cultures were shaken at 200 rpm at 37 °C for roughly 3 h or until an optical of density of 0.7–1.0 was 
reached.  Cultures were cooled on ice (20 min) and then induced by adding IPTG and aminolevulinic 
acid to a final concentration of 0.5 mM and 1.0 mM, respectively.  The cultures were allowed to continue 
for another 20 hours at 20 ºC and shaking at 200 rpm. Cell were harvested by centrifugation (4 °C, 15 
min, 3,000xg), and the cell pellet was stored at –20 °C or below for at least 2 h.  
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Purification was performed with an AKTA purifier FPLC system (GE Healthcare). For the purification of 
6XHis tagged P450s, the thawed cell pellet was resuspended in Ni-NTA buffer A (25 mM Tris.HCl, 200 
mM NaCl, 25 mM imidazole, pH 8.0, 4 mL/g of cell wet weight) and lysed by sonication (2x1 min,  30% 
duty cycle). The lysate was centrifuged at 27,000xg for 20 min at 4 °C to remove cell debris. The 
collected supernatant was subjected to a Ni-NTA chromatography step using a Ni Sepharose column 
(HisTrap-HP, GE healthcare, Piscataway, NJ). The P450 was eluted from the Ni Sepharose column using 
25 mM Tris.HCl, 200 mM NaCl, 300 mM imidazole, pH 8.0. Ni-purified protein was buffer exchanged 
into 0.1 M phosphate buffer (pH = 8.0) using a 10 kDa MW cut-off centrifugal filter.  Protein 
concentrations were determined by hemochrome binding assay described above.  For storage, proteins 
were portioned into 300 µL aliquots and stored at –80 °C.  
 
Small-scale whole-cell bioconversions  
E. coli BL21(DE3) cells with plasmid coding for a P450 mutant were grown from glycerol stock 
overnight (37 °C, 250 rpm) in 5 ml LBamp. A portion of the pre-culture (1.25 mL) was used to inoculate 
50 mL of Hyperbroth medium (1 L Hyperbroth prepared from powder from AthenaES©, 0.1 mg mL
-1
 
ampicillin) in a 250 mL Erlenmeyer flask and this culture was incubated at 37 °C, 200 rpm for 
approximately 3 h. At OD600 = 0.7–1.0, the cultures were cooled on ice (20 min) before inducing with 
IPTG (0.5 mM final concentration) and δ-aminolevulinic acid (1.0 mM final concentration). Shaking was 
continued at 20 ºC, 200 rpm. Cultures were harvested after 20 h and resuspended in nitrogen-free M9-N 
medium (1 L: 31 g Na2HPO4, 15 g KH2PO4, 2.5 g NaCl, 0.24 g MgSO4, 0.01 g CaCl2) until the indicated 
OD600 was reached (OD600 = 30 unless otherwise noted). Aliquots of the cell suspension were used for 
determination of the P450 expression level (2–3 mL) after lysis.   
Anaerobic reaction conditions: E. coli cells of the appropriate OD600 were transferred to a crimped 6 mL 
vial and degassed with argon for 5-10 min.  In parallel, a solution of glucose in M9-N (250 mM) was 
degassed with argon for the same period of time. All solutions were uncapped and transferred to an 
anaerobic chamber. Glucose solution (50 µL, 250 mM) was added to 2 mL crimp vials, followed by cell 
suspension (425 µL), the olefin substrate (12.5 µL of a 400 mM solution in EtOH), and EDA  (12.5 µL of 
a 800 mM solution in EtOH). The vials were sealed, removed from the anaerobic chamber and shaken on 
a tabletop shake plate at room temperature for 1 h at 350 rpm.  The reactions were quenched by addition 
of 20 µL of 3 M HCl, followed by 20 µL of the internal standard (20 mM 2-phenylethanol solution in 
cyclohexane) and 1 mL cyclohexane. The mixture was transferred to a 1.7 mL Eppendorf tube, vortexed 
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and then centrifuged (10,000x rcf, 30 s).  The organic layer was removed and analyzed by GC to 
determine yield and chiral SFC to determine enantioselectivity. 
 
Small-scale cyclopropanation reactions with purified enzymes (anaerobic)  
Small-scale (400 µL) reactions were carried out in 2 mL glass crimp vials (Agilent Technologies, San 
Diego, CA). P450 solution (60 µL, 67 µM) was added to an unsealed crimp vial. In parallel, a 12.5 mM 
solution of sodium dithionite in phosphate buffer (0.1 M, pH = 8.0) was degassed by bubbling with argon 
in a 6 mL crimp-sealed vial. All solutions were uncapped and transferred to an anaerobic chamber. The 
buffer/dithionite solution (320 µL) was added to each reaction vial containing P450 solution, followed by 
the olefin substrate (10 µL, 400 mM in EtOH) and EDA (10 µL, 800 mM in EtOH). The reaction vials 
were capped, removed from the anaerobic chamber, and then placed in a tray on a plate shaker and left to 
shake at 350 rpm for 2 h at room temperature.  The final concentrations of the reagents were typically: 10 
olefin, 20 mM EDA, 10 mM Na2S2O4, and 10 µM purified enzyme.  The reaction was quenched by the 
addition of 3 M HCl (20 µL), followed by 20 µL of the internal standard (20 mM 2-phenylethanol 
solution in cyclohexane) and 1 mL cyclohexane.  The mixture was transferred to a 1.7 mL Eppendorf 
tube and vortexed and centrifuged (10,000x rcf, 30 s). The organic layer was then analyzed by GC to 
determine yield and chiral SFC to determine enantioselectivity. 
 
Whole-cell reaction of 1 with EDA catalyzed by BM3-HStar variants 
Following the procedure for small-scale whole-cell bioconversions under anaerobic conditions (page SI-
5), whole cells expressing BM3-HStar, BM3-HStar H92N, BM3-HStar H100N, and BM3-HStar H92N 
H100N were grown and resuspended to OD600 = 10.  To determine the P450 concentration of each 
sample, 2 mL of each cell stock was removed and then analyzed by ferrous concentration assays 
following the general procedure outlined above.  
Small-scale reactions were performed following the general procedure with 12.5 µL 1 at 400 mM 
and 12.5 µL EDA at 800 mM.  Reactions were shaken for 2 h at room temperature.  GC analysis of 
product 2 was performed using J&W HP-5 column (30 m x 0.32 mm, 0.25 µM film) with the method 90 
°C hold 2 min, 90-110 at 6 °C/min, 110-190 at 40 °C/min, 190-280 at 20 °C/min, 280 °C hold 1 min, 
12.8 min total): internal standard (3.55 min), trans-2 (9.55 min), and cis-2 (9.69 min). Yields of 
cyclopropanation products were determined using calibration curves previously described in reference 1. 
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Analytical SFC of product 2 was performed on a Chiralpak AS column, eluting with 2% iPrOH at 2.5 
mL/min: λ = 210 nm, tR (min): major = 8.50, minor = 9.48. 
 
Reaction of acrylamide 1 with EDA and purified enzymes 
Small-scale reactions with isolated proteins were performed with purified BM3-HStar variants following 
the general procedure outlined on page SI-6, with 10 µM enzyme concentration, 10 mM of 1, and 20 mM 
of EDA at room temperature.  Yields of the reactions were determined by GC and enantioselectivities 
were determined by chiral SFC using the methods described above for whole-cell reactions.  
 
Analysis of diazo-induced inactivation 
Small-scale reaction mixtures with whole cells expressing the appropriate enzyme variants or purified 
enzymes were prepared according to the general procedures outlined above. To the reaction vial was 
added 10 µL of EDA solution (800 mM in EtOH). After the specified pre-incubation time, 10 µL of 
olefin solution (400 mM in EtOH) was added. For determination of olefin-induced inactivation, the order 
of addition was reversed. The reactions were shaken on a tabletop shake plate at room temperature for 1 h 
at 350 rpm.  The reactions were quenched by addition of 20 µL of 3 M HCl, followed by 20 µL of the 
internal standard (20 mM 2-phenylethanol solution in cyclohexane) and 1 mL cyclohexane. The mixture 
was transferred to a 1.7 mL Eppendorf tube, vortexed and then centrifuged (10,000x rcf, 30 s).  The 
organic layer was removed and analyzed by GC to determine yield and by chiral SFC to determine 
enantioselectivity. 
 
Liquid chromatography-mass spectrometry (LCMS) analysis of cofactor modification 
To a 6 mL crimp-sealed vial was added BM3-HStar (final concentration = 10 µM) and the vial was made 
anaerobic by degassing the headspace with argon for 10 min. In a separate 6 mL crimp-sealed vial, a 12.5 
mM solution of Na2S2O4 in phosphate buffer (0.1 M, pH = 8.0) was degassed by bubbling with argon for 
10 min. The buffer/dithionite solution (1.8 mL) was then added to the reaction vial via syringe, followed 
by 50 µL of 200 mM EDA solution. For investigation of reductant effects, degassed phosphate buffer 
solution (1.8 mL) was added in place of buffer/dithionite solution. The reaction was quenched at the 
appropriate time points by adding 100 µL of 3 M HCl, followed by 2.5 mL of 9:1 
dichloromethane:MeOH. The mixture was transferred to a 15 mL Falcon tube, vortexed and centrifuged 
(5000 rpm, 5 min). The organics were collected, and the extraction procedure was repeated one more 
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time. The organics were combined, concentrated in vacuo, redissolved in MeCN, and submitted for 
LCMS analysis. For reaction progress monitoring, the analyses were performed at 15 s and 1 min time 
points.  
 
Isolation of modified porphyrin cofactor 
Cofactor was extracted from the reaction mixture of isolated BM3-HStar and EDA using the procedure 
outlined above. Following extraction, the crude organics were concentrated in vacuo and then purified by 
preparative TLC (10:90:0.1 MeOH:DCM:AcOH), isolating the red fluorescent band (Rf = 0.3). The 
isolated porphyrin was dissolved in MeOH and then submitted to HRMS analysis. UV-vis analysis was 
performed using a solution of isolated porphyrin in DCM. For UV-vis analysis of Zn
2+
-complexed 
porphyrin, isolated porphyrin was dissolved in 0.5% ZnCl2 solution in 5:95 MeOH/DCM and submitted 
for analysis. 
 
Analysis of enzyme modification by intact protein mass determination 
Small-scale reactions were performed following the general procedure for catalysis using purified 
enzyme. The protein samples were analyzed on an LC-MSD SL 1100 series (Agilent) liquid 
chromatography mass spectrometry system. The samples were subjected to reverse phase 
chromatography on a 2.1 x 150 mm Zorbax 300SB-C3 column (Agilent) using a gradient consisting of 
0.2% formic acid (solvent A) and 0.2% formic acid in acetonitrile (89.8%) and methanol (10%) (solvent 
B). Eluted intact proteins were ionized using electrospray ionization and measured in the single 
quadrupole mass spectrometer and quantified. 
 
Alkylation analysis by bottom-up proteomics 
Small-scale reactions were performed following the general procedure for catalysis using purified 
enzyme. Appropriate amounts of the reaction aliquot were lyophilized to afford 10–20 µg of proteins. 
Dried pellets were dissolved in 40 µL of 8 M urea/100 mM Tris-HCl (pH 8.5) mixture. Proteins were 
reduced by addition of 0.25 µL of 500 mM TCEP (tris(2-carboxyethyl)-phosphine hydrochloride) and 
alkylated by addition of 0.9 µL of 500 mM iodoacetamide. For sample digestion, 1 µL of 0.1 gL
-1
 of 
lysyl endopeptidase (from A. lyticus) in 100 mM Tris-HCl (pH 8.5) was added, and the samples were 
incubated at room temperature for 4 h in the dark. The samples were diluted with 120 µL of 100 mM 
Tris-HCl (pH 8.5) and 1.6 µL of 100 mM CaCl2, followed by addition of 1 µL of 0.5 gL
-1
 of trypsin. 
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After overnight incubation at room temperature, the digested mixture was diluted to 5% formic acid 
concentration, desalted and lyophilized, and then resuspended in 0.2% formic acid solution for analysis. 
In-solution digested samples were subjected to LC-MS/MS analysis on a nanoflow LC system, EASY-
nLC II, (Thermo Fisher Scientific) coupled to a LTQ Orbitrap mass spectrometer (Thermo Fisher 
Scientific, Bremen, Germany) equipped with a Nanospray Flex ion source (Thermo Fisher Scientific). 
For the EASY-nLC II system, solvent A consisted of 97.8% H2O, 2% ACN, and 0.2% formic acid and 
solvent B consisted of 19.8% H2O, 80% ACN, and 0.2% formic acid. Samples were directly loaded onto 
a 16-cm analytical HPLC column (75 mm ID) packed in-house with ReproSil-Pur C18AQ 3 µm resin 
(120A° pore size, Dr. Maisch, Ammerbuch, Germany). The column was heated to 45° C. The peptides 
were separated with a 90 min gradient at a flow rate of 350 nL/min. The gradient was as follows: 2–30% 
Solvent B (90 min), 30–100% B (1 min), and 100% B (9 min). Eluted peptides were then ionized using a 
standard coated silica tip (New Objective, Woburn, MA) as an electrospray emitter and introduced into 
the mass spectrometer.  The LTQ Orbitrap was operated in a data-dependent mode, automatically 
alternating between a full-scan (m/z 300-1700) in the Orbitrap and subsequent MS/MS scans of the 15 
most abundant peaks in the linear ion trap (Top15 method). Data acquisition was controlled by Xcalibur 
2.0.7 and Tune 2.4 software (Thermo Fisher Scientific). 
Raw files were searched using MaxQuant (v 1.5.1.2) using default parameters except where 
noted. UniProt E. coli entries along with expressed protein sequence and a contaminant database were 
considered in the search. A decoy database was generated and searched in parallel to estimate the false 
discovery rate (FDR). Trypsin was specified as the digestion enzyme with up to two missed cleavages 
allowed. Precursor mass tolerance was 4.5 ppm after recalibration and fragment ion mass tolerance was  
0.5 Da. Variable modifications included carbamidomethylation of cysteine (+57.0215 Da), oxidation of 
methionine (+15.9949 Da), protein N-terminal acetylation (+42.0106 Da), and the custom modification 
(+86.0368 Da) on lysine, cysteine, histidine, serine, and arginine. FDRs of Peptide Spectrum Matches 
(PSM), Protein, and site modifications were all less than 1% as estimated by the target-decoy approach. 
 
Circular dichroism analysis 
Small-scale reactions were performed following the general procedure for catalysis using the heme 
domain of the appropriate enzyme variants after isolation and purification by HisTrap-HP column (final 
concentrations: 10 µM protein, 2 mM substrates, 2 mM Na2S2O4). CD samples were obtained by mixing 
20 µL aliquot of the reaction with 1.0 mL of 10 mM phosphate buffer (pH 8), and 2.0 mL of H2O. CD 
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spectra were recorded in the far UV region, 190–260 mm, using a quartz cell with 1 cm optical path 
length. Measurements were taken every 1 nm at a scan rate of 1 nm/sec.  
 
Amino Acid Sequences 
Table S1. Amino acid sequences of mutants, relative to wild type BM3 (WT). All mutations listed below 
are in the heme domain. There are no mutations present in the reductase domain. 
 
Enzyme Amino acid substitution with respect to WT 
BM3-HStar V78M, L181V, T268A, C400H, L437W 
BM3-HStar H92N V78M, H92N, L181V, T268A, C400H, L437W 
BM3-HStar H100N V78M, H100N, L181V, T268A, C400H, L437W 
BM3-HStar H92N H100N 
V78M, H92N, H100N, L181V, T268A, C400H, 
L437W 
 
Table S2. Total turnover numbers (TTN), diastereoselectivities, and enantioselectivities of whole-cell 
bioconversions of 1 and EDA.
a
 
 
Variant TTN %trans %ee 
BM3-Hstar 7400 91 61 
Hstar H92N 10900 91 82 
Hstar H100N 12300 95 69 
Hstar H92N H100N 20100 96 83 
 
a
Experiments were performed at room temperature using whole cells expressing the BM3-HStar variant, 
resuspended to OD600 = 10, with 10 mM 1, and 20 mM EDA. Results are the average of experiments 
performed with three independent batches of E. coli cultures, each used to perform three independent 
chemical reactions (total of 9 reactions for each enzyme variant). ee = enantiomeric excess. 
 
 
 
 
Table S3. Total turnover numbers (TTN), diastereoselectivities, and enantioselectivities of reaction of 1 
and EDA with purified enzymes.
a
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Variant TTN %trans %ee 
BM3-Hstar 310 92 10 
Hstar H92N 360 93 61 
Hstar H100N 420 91 57 
Hstar H92N H100N 560 98 89 
 
a
Results are the average of three independent chemical reactions, performed with 10 µM enzyme 
concentration, 10 mM of 1, 20 mM of EDA, and 10 mM of Na2S2O4 at room temperature. 
 
Table S4. Enantioselectivities of whole-cell bioconversions with varying concentrations of 1 and 
EDA.
a
 
Variant 1 (mM) EDA (mM) % ee 
BM3-Hstar 10 20 92 
BM3-Hstar 20 40 86 
BM3-Hstar 50 100 50 
BM3-Hstar 150 300 0 
Hstar H92N H100N 10 20 98 
Hstar H92N H100N 20 40 90 
Hstar H92N H100N 50 100 49 
Hstar H92N H100N 150 300 0 
a
Experiments were performed at room temperature using whole cells expressing the BM3-HStar variant, 
resuspended to OD600 = 60, with reactant concentrations described in the table.  
 
Whole-cell reaction of styrene with EDA catalyzed by BM3-HStar variants 
Following the procedure for small-scale whole-cell reactions under anaerobic conditions, E. coli 
expressing BM3-HStar, and BM3-HStar H92N H100N were grown and resuspended to OD600 = 10.  To 
determine the P450 concentration of each sample, 2 mL of each cell stock was removed and analyzed by 
ferrous concentration assays following the general procedure outlined above. Small-scale reactions were 
performed following the general procedure with 10 mM final concentrations each of styrene and EDA.  
Reactions were shaken for 2 h at room temperature.  GC analysis of product 2 was performed using J&W 
HP-5 column (30 m x 0.32 mm, 0.25 µM film) with the method 90 °C hold 2 min, 90-190 at 6 °C/min, 
190-230 °C at 40 °C/min, 230 °C hold 2 min (internal standard: 3.19 min, Z product 8.97 min, E product 
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9.99 min). Yields of cyclopropanation products were determined using calibration curves previously 
described in reference 1. 
 
Whole-cell reaction of aniline with EDA catalyzed by BM3-HStar variants 
Following the procedure for small-scale whole-cell reactions under anaerobic conditions, E. coli 
expressing BM3-HStar, and BM3-HStar H92N H100N were grown and resuspended to OD600 = 10.  To 
determine the P450 concentration of each sample, 2 mL of each cell stock was removed and analyzed by 
ferrous concentration assays following the general procedure outlined above. Small-scale reactions were 
performed following the general procedure with 20 mM and 10 mM final concentrations of aniline and 
EDA, respectively.  Reactions were shaken for 2 h at room temperature.  GC analysis of product 2 was 
performed using J&W HP-5 column (30 m x 0.32 mm, 0.25 µM film) with the method 90 °C hold 2 min, 
90-190 at 6 °C/min, 190-230 °C at 40 °C/min, 230 °C hold 2 min (internal standard: 3.19 min, product 
9.84 min). Yields of N–H insertion product were determined using calibration curves described below. 
 
Calibration curve for carbenoid N–H insertion into aniline 
 
 
Enantioselectivity for cyclopropanation of N,N-diethyl-2-phenylacrylamide (1) catalyzed by BM3-
HStar variants 
Racemic mixture 
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Purified BM3-HStar 
 
 
Purified HStar H92N 
 
Purified HStar H100N 
 
Purified HStar H92N H100N 
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BM3-HStar (whole cell, OD600 = 10) 
 
 
 
 
HStar H92N (whole cell, OD600 = 10) 
 
HStar H100N (whole cell, OD600 = 10) 
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HStar H92N H100N (whole cell, OD600 = 10) 
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Figure S1. Pre-incubation experiments with EDA (top left, reaction with whole cells expressing the 
enzyme; top right, reaction with purified enzyme) showed rapid loss in activity and enantioselectivity, 
suggesting EDA-induced inactivation. For whole-cell experiments, reactions were performed with whole 
E. coli cell suspension (OD600 = 60), 10 mM of 1, and 20 mM of EDA. For experiments with purified 
enzyme, reactions were performed with purified BM3-HStar (10 µM), 10 mM of 1, and 20 mM of EDA. 
Pre-incubation experiments with EDA in the absence of Na2S2O4 (bottom graph) showed that the enzyme 
maintained its activity in the absence of reductant; reaction conditions: purified BM3-HStar (10 µM), 10 
mM of 1, and 20 mM of EDA, with Na2S2O4 solution added concurrently with 1.  
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+ N2 CO2Et
Na2S2O4,
Mb H64V V68A
(10 µM)
(pre-incubate
for X min)
CO2Et
 
 
 
 
Before 
reaction  
After reaction  
 
Figure S2. Decrease in cyclopropanation activity of Mb H64V V68A after pre-incubation with EDA, and 
LC-MS analysis of heme content of the protein, before and after treatment with EDA. Reaction was 
performed at room temperature, with 10 µM of purified Mb H64V V68A, 10 mM of styrene, and 20 mM 
of EDA. 
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Before reaction 
 
After reaction 
 
 
 
Figure S3. Outcome of intramolecular C–H amination reaction of S1, with and without pre-incubation 
with EDA, and LC-MS monitoring of heme content of the protein, before and after treatment with EDA.  
P-I263F = P450-BM3 V78A F87V T175I A184V S226R H236Q E252G I263F T268A A290V L353V 
I366V C400S T438S E442K, this enzyme was previously reported by our laboratory to catalyze 
regioselective intramolecular C–H amination on S1 (see Hyster, T. K.; Farwell, C. C.; Buller, A. R.; 
Arnold, F. H. J. Am. Chem. Soc. 2014, 136, 15505–15508). Reaction was performed at room temperature 
with 10 µM of purified P-I263F, 10 mM of EDA, 2.5 mM of S1, and 10 mM of NADPH.  
  SI-20 
 
 
 
 
 
Figure S4. Comparison of absorption spectra of isolated porphyrin species from BM3-HStar after 
cyclopropanation reaction with that of authentic protoporphyrin IX (PPIX) standard. 
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Figure S5. Intact mass spectra of unreacted BM3-HStar heme domain (left) and at the end of reaction 
with 1 and EDA (right), exhibiting extreme heterogeneity. Mass spectra can be deconvoluted to reveal 
the presence of multiply-modified protein species.  
 
Table S5. Representative deconvolution of purified, intact protein
 a
 
Expected mass (Da) Observed mass (Da) ppm error EDA equivalents 
53,866 53,871 93 0 
 
a
 Error on the LC-MSD SL 1100 series is approximately 100 ppm, or ± 5.4 Da in a 54000 Da protein. 
Table S6. Representative deconvolution of EDA-treated, intact protein
 a
 
 
Expected mass (Da) Observed mass (Da) ppm error EDA equivalents 
53,866 53,870 74 0 
53,953 53,953 3 1 
54,039 54,040 17 2 
54,125 54,125 4 3 
54,211 54,212 24 4 
54,297 54,300 64 5 
54,383 not detected 
not 
determined 
6 
54,469 54,477 147 7 
 
a
 Error on the LC-MSD SL 1100 series is approximately 100 ppm, or ± 5.4 Da in a 54000 Da protein.
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K76 and R79 modifications 
 
C62, K69, and S72 modifications 
 
Figure S6. MS/MS spectra of modified peptide fragments from the cyclopropanation reaction mixture 
with BM3-HStar after trypsin digestion. “Ʌ” indicates site of modification. 
 
 
K69
 
Figure S7. Polar contact between K69 and the propionate side-chain of the heme in P450-BM3. 
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Figure S8. Comparison of TTNs for styrene cyclopropanation and carbenoid insertion into N–H bond of 
aniline between HStar and HStar H92N H100N. Reaction conditions for cyclopropanation: whole E. coli 
cells expressing the enzyme variant (suspension in M9-N, OD600 = 10), 10 mM of styrene, 10 mM of 
EDA, room temperature, 2 h. Reaction conditions for N–H insertion: whole E. coli cells expressing the 
enzyme variant (suspension in M9-N, OD600 = 10), 20 mM of aniline, 10 mM of EDA, room temperature, 
2 h. 
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Figure S9. Time-course of cyclopropanation of 1 with EDA using whole E. coli cells expressing BM3-
HStar variants. Reaction conditions: whole E. coli cells expressing enzyme variants (OD600 = 10, 0.2 µM 
enzyme), 10 mM of 1, 20 mM of EDA, room temperature. 
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Figure S10. Circular dichroism (CD) spectra of ferrous BM3-HStar H92N H100N before (black) and 
after reaction with EDA (red). 
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S89 and K97 modifications 
 
 
 
S304 and K306 modifications 
 
 
LCMS analysis of heme modification, before reaction 
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LCMS analysis of heme modification, after reaction 
 
 
Figure S11. (Top panels) MS/MS spectraof modified peptide fragments from the cyclopropanation 
reaction mixture with BM3-HStar H92N H100N after trypsin digestion. New modification sites at 
residues S89, K97, S304, and K306 were observed even though residues N92 and N100 were not 
modified in the reaction. Additionally, modification of heme cofactor was also observed during the 
reaction. (Bottom panels) LC-MS chromatograms of the organic extract from BM3-HStar H92N H100N 
before and after reaction with EDA.  
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